s6y
Company name or ticker
Search
Brown Martin S JR
3
CUMBERLAND PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
Filed
Monday, July 25, 2022
Period
Jul 15, 2022
Accession number
0001209191-22-043130
Documents
FORM 3 SUBMISSION
3
POA DOCUMENT
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header